Covid-19 and Cancer

AUTHOR(s) : Kataki Amal Chandra, Boro Sumanjit S, Medhi Partha Pratim, Bansal Shashank, Kataki Kaushik J
DOI No. : 10.31741/ijhrmlp.v6.i2.2020.14

Coronavirus disease (COVID-19) has affected healthcare delivery all across the globe, particularly for chronic diseases like cancer. Everyday new literature and guidelines are emerging. In this review article, we aimed to discuss the essential insights of cancer care during COVID-19 pandemic. Cancer patients are at higher risk of morbidity and mortality from Ovid-19. Yet they should not be deprived of necessary treatment while minimizing the risks of the spread of COVID-19 at the same time. Different recommendations about surgery, chemotherapy, radiotherapy and general cancer care have been proposed by different leading groups on how to deal with cancer during Coronavirus pandemic. Although these are troubled times with limitations in resources and challenges in providing healthcare, yet there is a need to evaluate cancer patients on case to case basis and deliver optimum care to all.Keywords: SARS-CoV-2; cancer care; pandemic.
Keywords: SARS-CoV-2; cancer care; pandemic.

Registered Office Address:
House No: One, Karmabir Bordoloi Path, Wireless,
Rukmini Nagar, Dispur-06, Assam, India

Mobile: 09435017802
IJHRMLP is an open-access journal, and the articles published are instantly available to read and use again. The published articles thus can be downloaded, shared, and reused without restriction if the contributing original authors are appropriately cited. Author(s) retain the copyright of their article, with articles licensed to AHRME and the journal following the Creative Commons Attribution License (CC-BY).
Maintain By Prism Infosys